Vaxart, Inc.

VXRT ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $186.1M

Liabilities Breakdown FY2025

Total Liabilities: $98.3M